S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
PRI   135.45 (+0.13%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
PRI   135.45 (+0.13%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
PRI   135.45 (+0.13%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
S&P 500   3,141.63 (+0.29%)
DOW   27,911.30 (+0.11%)
QQQ   204.98 (+0.53%)
AAPL   270.77 (+0.85%)
FB   202.26 (+0.69%)
MSFT   151.70 (+0.38%)
GOOGL   1,344.25 (+0.10%)
AMZN   1,748.72 (+0.55%)
CGC   20.25 (+0.80%)
NVDA   217.34 (+1.57%)
BABA   204.64 (+2.09%)
GE   10.97 (-0.36%)
T   38.17 (+0.29%)
AMD   39.47 (+0.08%)
PRI   135.45 (+0.13%)
GILD   67.78 (+1.04%)
DIS   147.59 (+1.02%)
Log in

NASDAQ:CBST - Cubist Pharmaceuticals Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cubist Pharmaceuticals, Inc (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in other acute care settings. As of December 31, 2011, the Company had two marketed products, CUBICIN (daptomycin for injection) and ENTEREG (alvimopan). Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
Current SymbolNASDAQ:CBST
CUSIP22967810
Phone+1-781-8608660

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CBST News and Ratings via Email

Sign-up to receive the latest news and ratings for CBST and its competitors with MarketBeat's FREE daily newsletter.


Cubist Pharmaceuticals (NASDAQ:CBST) Frequently Asked Questions

What is Cubist Pharmaceuticals' stock symbol?

Cubist Pharmaceuticals trades on the NASDAQ under the ticker symbol "CBST."

How were Cubist Pharmaceuticals' earnings last quarter?

Cubist Pharmaceuticals Inc (NASDAQ:CBST) released its earnings results on Tuesday, October, 21st. The biopharmaceutical company reported $0.58 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.54. The biopharmaceutical company had revenue of $309.20 million for the quarter, compared to analyst estimates of $305.50 million. The business's revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.41 EPS. View Cubist Pharmaceuticals' Earnings History.

Has Cubist Pharmaceuticals been receiving favorable news coverage?

News articles about CBST stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cubist Pharmaceuticals earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Cubist Pharmaceuticals.

Who are some of Cubist Pharmaceuticals' key competitors?

What other stocks do shareholders of Cubist Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cubist Pharmaceuticals investors own include Intercept Pharmaceuticals (ICPT), Ionis Pharmaceuticals (IONS), Netflix (NFLX), Novavax (NVAX), Seattle Genetics (SGEN), Qihoo 360 Technology (QIHU), Baidu (BIDU), Booking (BKNG), BioMarin Pharmaceutical (BMRN) and CalAmp (CAMP).

What is Cubist Pharmaceuticals' official website?

The official website for Cubist Pharmaceuticals is http://www.cubist.com/.

How can I contact Cubist Pharmaceuticals?

Cubist Pharmaceuticals' mailing address is 65 Hayden Ave, LEXINGTON, MA 02421-7994, United States. The biopharmaceutical company can be reached via phone at +1-781-8608660.


MarketBeat Community Rating for Cubist Pharmaceuticals (NASDAQ CBST)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  250 (Vote Outperform)
Underperform Votes:  248 (Vote Underperform)
Total Votes:  498
MarketBeat's community ratings are surveys of what our community members think about Cubist Pharmaceuticals and other stocks. Vote "Outperform" if you believe CBST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2019 by MarketBeat.com Staff

Featured Article: Cash Asset Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel